Progress Made in Developing Methamphetamine Vaccine

Progress Made in Developing Methamphetamine Vaccine

By Rick Nauert, PhD


Researchers report promising advances in the lab toward the development of a vaccine to treat methamphetamine addiction.

Although the abuse of “speed” or methamphetamines is under the radar screen for many, the costs associated with the addiction are astronomical exceeding $23 billion annually. Expenditures include medical and law enforcement outlays as well as lost productivity.

In the paper, Kim Janda, Ph.D., and colleagues note that “meth” or “crystal meth” can cause a variety of problems including cardiovascular damage and death. Meth is highly addictive, and users in conventional behavioral treatment programs often relapse.

Full story at PsychCentral